PROVIDER PROFILE · NPI 1649254525

Mark Cardamone-Rayner

OtolaryngologyMankato, MNI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

218

Beneficiaries

—

Total drug cost

$65K

Distinct drugs

Brand share

29.4%

Top prescribed drugs

Levothyroxine Sodium51 claims

Famotidine36 claims

Ciprofloxacin Hcl/Dexameth28 claims

Mometasone Furoate22 claims

Oxycodone Hcl/Acetaminophen21 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$59

Payment records

By payment type

Food and Beverage$59

REFERRAL NETWORK

Where Mark Cardamone-Rayner's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
MAYO CLINIC HEALTH SYSTEM-SOUTHWEST MINNESOTA REGION	176	649
MAYO CLINIC HEALTH SYSTEM-SOUTHWEST MINNESOTA REGION	66	275
Mayo Collaborative Services, Inc Clinical Laboratory · Rochester, MN	33	71
Jennifer Tunnell Audiologist · Mankato, MN	17	28
Nicole Krueger Audiologist · Mankato, MN	17	28
Warren Stanchfield Diagnostic Radiology · Mankato, MN	12	22
Peter Reichert Diagnostic Radiology · Mankato, MN	11	30

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history